Literature DB >> 1925717

Hypermobility and deconditioning: important links to fibromyalgia/fibrositis.

J A Goldman1.   

Abstract

In this study 210 patients who were identified as having fibromyalgia/fibrositis were evaluated for hypermobility of joints. The patients were then instructed to perform an exercise program, and thereafter their compliance with the program and its effect on their symptoms were evaluated. The data were then analyzed using the Student's t test and Pearson's correlation coefficient. Patients who exercised during the study had improvement. Because the hypermobile patients as a group exercised more than the nonhypermobile group, they showed greater improvement than the nonhypermobile group (58% versus 30%). Patients with fibromyalgia/fibrositis who have articular hypermobility are more likely to exercise, which will improve their symptoms. The ability to show the objective findings of hypermobility to a person with fibromyalgia/fibrositis, a diagnosis based on subjective symptoms and signs, facilitates management of the patient. These tangible signs help the patient accept and adjust to the diagnosis of fibromyalgia/fibrositis.

Entities:  

Mesh:

Year:  1991        PMID: 1925717     DOI: 10.1097/00007611-199110000-00008

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  4 in total

Review 1.  Use of exercise for treatment of chronic fatigue syndrome.

Authors:  K K McCully; S A Sisto; B H Natelson
Journal:  Sports Med       Date:  1996-01       Impact factor: 11.136

Review 2.  Evaluation of treatments for myofascial pain syndrome and fibromyalgia.

Authors:  Nathan J Rudin
Journal:  Curr Pain Headache Rep       Date:  2003-12

3.  Clinical and demographic characteristics and functional status of the patients with fibromyalgia syndrome.

Authors:  Nilay Sahin; Aziz Atik; Erdal Dogan
Journal:  North Clin Istanb       Date:  2014-12-08

4.  Ehlers-danlos syndrome, hypermobility type: an underdiagnosed hereditary connective tissue disorder with mucocutaneous, articular, and systemic manifestations.

Authors:  Marco Castori
Journal:  ISRN Dermatol       Date:  2012-11-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.